Q4 2024 Holdings
Filed 2025-02-14 | 89 holdings | $750.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Gilead Sciences Inc(GILD) | COM | 375558103 | $34.6M | 374,825 | 4.6% |
| Verona Pharma PLC(VRNA) | SPONSORED ADS | 925050106 | $33.5M | 720,657 | 4.5% |
| Insulet Corp(PODD) | COM | 45784P101 | $32.8M | 125,761 | 4.4% |
| Boston Scientific Corp(BSX) | COM | 101137107 | $30.1M | 337,354 | 4.0% |
| Stryker Corporation(SYK) | COM | 863667101 | $28.0M | 77,717 | 3.7% |
| Cooper COS Inc(COO) | COM | 216648501 | $25.2M | 274,569 | 3.4% |
| ELI Lilly & Co(LLY) | COM | 532457108 | $21.7M | 28,163 | 2.9% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $20.8M | 1,087,634 | 2.8% |
| Intra-Cellular Therapies Inc(ITCIEUR) | COM | 46116X101 | $20.3M | 243,123 | 2.7% |
| Mannkind Corp(MNKD) | COM NEW | 56400P706 | $20.1M | 3,126,727 | 2.7% |
| Abbott Labs(ABT) | COM | 002824100 | $20.0M | 176,994 | 2.7% |
| Travere Therapeutics Inc(TVTX) | COM | 89422G107 | $19.5M | 1,117,792 | 2.6% |
| Arcus Biosciences Inc(RCUS) | COM | 03969F109 | $19.0M | 1,273,789 | 2.5% |
| Becton Dickinson & Co(BDX) | COM | 075887109 | $16.0M | 70,404 | 2.1% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $15.8M | 115,727 | 2.1% |
| Kiniksa Pharmaceuticals Intl(KNSA) | ORD SHS CL A | G52694109 | $15.1M | 765,453 | 2.0% |
| Quest Diagnostics Inc(DGX) | COM | 74834L100 | $13.6M | 90,352 | 1.8% |
| Tenet Healthcare Corp(THC) | COM NEW | 88033G407 | $13.5M | 106,987 | 1.8% |
| United Therapeutics Corp del(UTHR) | COM | 91307C102 | $13.2M | 37,472 | 1.8% |
| Mckesson Corp(MCK) | COM | 58155Q103 | $13.1M | 23,000 | 1.7% |
| DAY One Biopharmaceuticals I(DAWN) | COM | 23954D109 | $12.7M | 1,000,474 | 1.7% |
| Qiagen NV(QGEN) | SHS NEW | N72482149 | $12.3M | 277,272 | 1.6% |
| Cvrx Inc(CVRX) | COM | 126638105 | $11.7M | 921,174 | 1.6% |
| Schrodinger Inc(SDGR) | COM | 80810D103 | $10.9M | 563,091 | 1.4% |
| Edwards Lifesciences Corp(EW) | COM | 28176E108 | $10.8M | 145,214 | 1.4% |
| Replimune Group Inc(REPL) | COM | 76029N106 | $10.5M | 869,759 | 1.4% |
| Rxsight Inc(RXST) | COM | 78349D107 | $10.3M | 300,698 | 1.4% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $10.2M | 381,173 | 1.4% |
| Unitedhealth Group Inc(UNH) | COM | 91324P102 | $10.1M | 20,000 | 1.3% |
| Nurix Therapeutics Inc(NRIX) | COM | 67080M103 | $10.0M | 532,172 | 1.3% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $9.5M | 116,138 | 1.3% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $9.1M | 38,672 | 1.2% |
| Castle Biosciences Inc(CSTL) | COM | 14843C105 | $8.1M | 304,629 | 1.1% |
| Livanova PLC(LIVN) | SHS | G5509L101 | $8.1M | 174,934 | 1.1% |
| CVS Health Corp(CVS) | COM | 126650100 | $8.1M | 180,000 | 1.1% |
| PTC Therapeutics Inc(PTCT) | COM | 69366J200 | $8.0M | 177,368 | 1.1% |
| Quidelortho Corp(QDEL) | COM | 219798105 | $7.8M | 175,415 | 1.0% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $7.6M | 193,004 | 1.0% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $7.4M | 784,376 | 1.0% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $7.0M | 526,973 | 0.9% |
| Dexcom Inc(DXCM) | COM | 252131107 | $6.1M | 78,550 | 0.8% |
| Axogen Inc(AXGN) | COM | 05463X106 | $6.0M | 365,703 | 0.8% |
| Keros Therapeutics Inc(KROS) | COM | 492327101 | $5.0M | 314,541 | 0.7% |
| Bicycle Therapeutics PLC(BCYC) | SPONSORED ADS | 088786108 | $4.9M | 352,481 | 0.7% |
| Uniqure NV(QURE) | SHS | N90064101 | $4.9M | 275,000 | 0.6% |
| Jazz Pharmaceuticals PLC(JAZZ) | SHS USD | G50871105 | $4.6M | 37,751 | 0.6% |
| Terns Pharmaceuticals Inc(TERN) | COM | 880881107 | $4.6M | 829,105 | 0.6% |
| Teva Pharmaceutical Inds LTD(TEVA) | SPONSORED ADS | 881624209 | $4.3M | 196,805 | 0.6% |
| Ultragenyx Pharmaceutical in(RARE) | COM | 90400D108 | $4.2M | 100,159 | 0.6% |
| Veracyte Inc(VCYT) | COM | 92337F107 | $4.0M | 100,301 | 0.5% |